Physical Gel Network Integrity in Radiation Sterilized Wound Hydrogels

Terminal radiation sterilization of wound hydrogels represents a physicochemical boundary condition in which ISO 11137-1:2006/Amd 1:2013 dose delivery and the preservation of a physical rather than covalent gel network coexist only within narrow formulation and process limits. A physical gel derives its plateau modulus, equilibrium swelling, and creep resistance from hydrogen bonding, polymer crystallite bridging, helix formation, ionic association, or hydrophobic domain clustering rather than from crosslinker-driven covalent bonds. The interaction energy per junction is often below 10 kJ mol⁻¹ for hydrogen bonds and 5–30 kJ mol⁻¹ for hydrophobic association, compared with 150–400 kJ mol⁻¹ for C–C bonds, so ionizing radiation does not merely terminate micro-organisms; it simultaneously generates hydroxyl radicals, aqueous electrons, hydrogen atoms, and macromolecular radicals that abstract hydrogen atoms, cleave glycosidic or backbone bonds, and recombine into new network defects. The practical consequence for a production-scale gamma cell is that a hydrogel dressing manufactured from freeze-thaw poly(vinyl alcohol) with 12–20% solids may pass bioburden reduction at 25 kGy, yet exhibit an altered gel fraction, reduced low-strain storage modulus, increased soluble polymer fraction, and a higher equilibrium swelling ratio when compared with the non-sterile control. The regulatory framework requires demonstration that the terminal sterilization process does not compromise the physical gel network integrity and that the sterilized device remains within its design specification under ISO 13485:2016 clause 7.5.7 and the design controls of 21 CFR 820.30. The following technical scenarios address the radiation physics, aqueous free-radical chemistry, rheological quantification, and production-scale process conflicts that determine whether a physical wound hydrogel can tolerate a terminal radiation dose without loss of clinical handling and exudate management functionality.

What Structural Transitions Occur in Noncovalent Networks During Co-60 Exposure?

Ionizing radiation absorbed by water present at 70–95 wt% generates primary radiolysis products with yields commonly expressed in μmol J⁻¹: hydroxyl radical (•OH) approximately 0.28 μmol J⁻¹, hydrated electron (e⁻aq) 0.28 μmol J⁻¹, hydrogen atom (H•) 0.06 μmol J⁻¹, and hydrogen peroxide (H₂O₂) 0.07 μmol J⁻¹. In aerated hydrogel matrices, dissolved oxygen reacts rapidly with carbon-centred macroradicals to form peroxyl radicals, which propagate β-scission reactions in polysaccharide backbones and abstract hydrogen from PVA methylene groups. The resulting carbonyl and hydroperoxide species reduce chain length, enlarge the soluble fraction, and weaken the physical network junctions. For a freeze-thaw PVA hydrogel, the noncovalent junctions are microcrystalline domains that form during cyclic freezing and thawing; their mean crystallite thickness, melting endotherm, and connectivity are altered by radiation because hydroxyl radical attack occurs preferentially at vicinal diol residues and amorphous chain folds while the nascent macroradicals are immobilised within a high-viscosity matrix. Gelatin hydrogels rely on triple-helix junction zones that melt below 37 °C; radiation-induced scission of primary chains reduces helix nucleation density and lowers the renaturation temperature, producing a gel that liquefies more readily on wound contact. Polysaccharide hydrogels such as agarose and alginate exhibit glycosidic bond scission and a dose-dependent loss of storage modulus; published data for this specific configuration is limited because alginate physical gels are frequently sterilised by filtration or aseptic processing rather than by terminal radiation. The quantitative outcome depends on dose, dose rate, oxygen tension, temperature during irradiation, and radical scavenger content. A Co-60 gamma source typically operates at 1–10 kGy h⁻¹, allowing radical diffusion distances to exceed those in high-dose-rate electron beam processing, which strongly affects whether radical recombination contributes to crosslinking or terminates by disproportionation.

Dose Mapping, Absorbed Dose Gradients, and Establishing Process Safety Margins

Production-scale gamma sterilization of preformed hydrogel wound dressings in sealed trays requires dose mapping per ISO 11137-3:2017 using alanine or radiochromic film dosimeters placed at minimum and maximum dose locations. The dose uniformity ratio (DUR) across a tote loaded with absorbent hydrogel pouches may vary from 1.2 to 1.7 depending on product density, package orientation, and conveyor path. A process target of 25 kGy may therefore produce absorbed doses from 21 kGy at the minimum monitored position to 36 kGy at the maximum; the material qualification must cover the entire observed range. In practice, a physical gel network that is stable at 25 kGy may fail at 35 kGy due to accumulative chain scission and crystallite destruction. Hydrogel dressings with high water activity and low dry-matter content are particularly sensitive because the radiolysis of water dominates the energy deposition and because the soluble fraction can diffuse within the primary packaging, producing a visible liquid layer at the edges. A production line using a continuous tote irradiator with multiple passes often records larger minimum-to-maximum spread when product density is nonuniform; this is addressed by adding dummy loading to compress the dose distribution and by selecting a lower sterilization dose substantiation such as 15 kGy or 20 kGy using ISO 11137-2:2013 method VDmax. The adoption of a reduced dose, however, must remain supported by bioburden data and cannot be justified solely by material compatibility. AAMI TIR29:2020 provides guidance for radiation sterilization process validation, including material effects and dose audit requirements. The process specification must state that the product is irradiated at refrigerated conditions 2–8 °C if the gel network is thermolabile, and that pre-irradiation drying is required where residual moisture exceeds 95 wt%. Failure to clamp ambient oxygen during irradiation allows peroxyl-mediated autoxidation to continue during storage, because trapped radicals in the gel may persist for weeks in amorphous PVA and polysaccharide matrices.

Rheological qualification of the radiation-sterilized hydrogel should be performed using a controlled-stress rotational rheometer equipped with a 40 mm 2° cone and Peltier plate set to 25 ± 0.1 °C; a solvent trap or humidity hood is mandatory to prevent evaporation during oscillation. The test sequence begins with an amplitude sweep at 1 Hz from 0.01% to 100% strain to identify the linear viscoelastic limit; for a wound hydrogel with a plateau modulus between 50 Pa and 5,000 Pa, the critical strain often falls below 10%. Frequency sweeps from 0.1 rad s⁻¹ to 100 rad s⁻¹ at 1% strain provide storage modulus G′, loss modulus G″, and loss tangent tan δ; a physical gel network is judged intact when G′ exceeds G″ by at least one decade and when G′ remains frequency-stable across the therapeutic range. Post-irradiation G′ loss of 20–40% at 1.0 rad s⁻¹ is commonly observed in polysaccharide physical gels at 25 kGy, whereas freeze-thaw PVA gels may show an initial apparent stiffening due to crosslinking followed by network embrittlement. Yield-stress measurements are conducted by controlled shear-rate ramps from 0.001 s⁻¹ to 100 s⁻¹; the stress overshoot is recorded as the yield stress. Syringeability or spreadability for wound application can be measured by a 20 mL syringe fitted with a 14 G cannula at a crosshead speed of 100 mm min⁻¹; the initial extrusion force should not exceed 15 N for manual applicators. Gel fraction is measured by extracting soluble polymer in deionized water at 25 °C for 24 h, with methodology adapted from ASTM D2765-16 for aqueous gel systems; the dry residue after lyophilization is normalised to the initial dry polymer mass. A radiation-sterilized hydrogel may be acceptable if the gel fraction remains above 70% of the pre-irradiation value and the equilibrium swelling ratio shifts by less than 25%. Batch-to-batch variance on production lines is influenced by the freeze-thaw cycle envelope, water content, and molecular weight distribution; a validated process should include upper and lower specification limits for G′ at 1.0 rad s⁻¹, yield stress, gel fraction, and soluble polyol content.

When Electron Beam Terminal Sterilization Replaces Gamma for High-Water-Activity Dressing Formats

Electron beam irradiation delivers dose at 10⁶–10⁸ kGy h⁻¹, producing a nearly adiabatic temperature rise and a far shorter radical diffusion interval than Co-60 gamma processing. For an aqueous gel with heat capacity near 4.18 kJ kg⁻¹ K⁻¹, a 25 kGy absorbed dose corresponds to a theoretical adiabatic temperature increase of approximately 6 °C, provided phase transitions are absent; local inhomogeneities in package thickness, air voids, and metal foils can create dose nonuniformity and hot spots. The high dose rate favours bimolecular radical termination over slow oxidative degradation during irradiation, but it also increases the probability of macroradical recombination into permanent covalent crosslinks. In practice, a poly(vinyl pyrrolidone)-based physical or weak covalent hydrogel may undergo progressive insoluble network formation at 15–35 kGy, causing a lower equilibrium swelling ratio and a stiffer gel unsuitable for wound exudate absorption. For polysaccharide gels, the high instantaneous radical concentration does not prevent glycosidic bond scission; e-beam processing at 10 MeV with conveyor speeds adjusted to deliver 25 kGy per pass can reduce molecular weight and lower the gel melting point. Production-scale e-beam equipment often operates at 10 MeV for low-density, water-bearing products; depth-dose penetration limits the maximum package thickness to approximately 3.8 cm for single-sided treatment at 10 MeV depending on density. A wound hydrogel pouch thicker than this requires double-sided irradiation or gamma processing. Because e-beam does not rely on a radioisotope source, it can be integrated into a manufacturing line after final packaging, but the process qualification under ISO 11137-1:2006/Amd 1:2013 must still establish the DUR and verify that the maximum dose does not degrade the physical gel network. The operational boundary for e-beam is set by oxygen diffusion: the short irradiation time does not allow ambient oxygen to be depleted, so peroxyl radical formation is controlled by oxygen solubility and post-irradiation diffusion. Packaging in low-oxygen-permeability trays with nitrogen flushing at residual oxygen below 2% is frequently required; otherwise, subsequent oxidative chain scission during storage can reduce the gel fraction by an additional 15–25% over 12 months at 25 °C.

Manufacturing-scale failure modes associated with radiation-sterilized physical wound hydrogels include syneresis with free water pooling at the pouch perimeter, phase separation in thermosensitive poloxamer gels, colour shifts due to radiolytic carbonyl and Maillard products, and a sticky surface caused by low-molecular-weight soluble polymer migration. A pouched hydrogel that appears homogeneous before irradiation may show localised thinning at the maximum dose position because the internal network yields under its own weight when the yield stress drops below the gravitational stress. This effect is quantified by measuring the yield stress after storage at 40 °C for 1 month; if the yield stress falls below 20 Pa, the gel is considered uncompensated for vertical pouch storage. Incompatibilities arise with amine-based buffering agents, certain antimicrobial agents, and transition-metal residues that catalyse Fenton-like chemistry and accelerate oxidative chain scission. For example, hydrogel formulations containing silver sulfadiazine may exhibit accelerated polymer degradation under radiation because silver nanoparticles and metal ions enhance radical generation at the polymer–water interface; formulations containing ascorbic acid or other antioxidants may protect the gel but may also interfere with the microbiocidal effectiveness of the radiation process if the antioxidant concentration exceeds 5 mM. Processing boundaries include pre-drying at relative humidity above 60%, not applicable to finished high-water wound gels but relevant for dry-powder intermediates; irradiation at temperatures above 25 °C should be avoided for gelatin and agarose physical gels because thermal melting during the irradiation cycle augments radiation-induced disruption and causes irreversible network collapse. A validated terminal radiation process for physical wound hydrogels therefore requires an integrated risk assessment that couples bioburden, absorbable dose, dose rate, temperature rise, oxygen availability, and post-irradiation stability across the entire shelf life.

Oxidative Chain Scission in Freeze-Thaw PVA Networks Cannot Be Reversed by Post-Irradiation Annealing

Freeze-thaw poly(vinyl alcohol) hydrogels derived from repeated freezing at -20 °C to -35 °C for 8–20 h and thawing at 4–25 °C for 4–12 h obtain their network integrity from crystalline PVA domains that act as physical crosslinks. Radiation-induced chain scission shortens the tie chains between crystallites, reduces the number of load-bearing segments, and lowers the gel modulus; radiation-induced oxidation also introduces ketone and carboxyl groups that increase the equilibrium swelling ratio and decrease the melting endotherm of the crystalline regions. A common misconception in process development is that a short post-irradiation annealing step at 60–70 °C can restore the original crystallite population; in practice, the oxidative scission products and trapped radicals cannot be eliminated by mild thermal treatment, and the original molecular weight distribution is not restored. During annealing, additional crystallisation may occur, but the network topology remains altered because the scissioned chains are no longer available to bridge adjacent crystallites. Data from production-scale freeze-thaw PVA dressings indicate that at absorbed doses above 35 kGy, the storage modulus at 1.0 rad s⁻¹ may fall by 30–50% and the equilibrium swelling ratio may increase by more than 40%; at doses above 50 kGy, the gel often fails to maintain a defined free-standing configuration and exhibits gross syneresis. These effects are magnified when the starting PVA has a low degree of hydrolysis (87–89%) and when the gel is processed with plasticisers that are themselves radiolabile. A radiation-sterilized PVA wound hydrogel should therefore be formulated with a degree of hydrolysis above 98%, a freeze-thaw cycle count sufficient to reach maximum crystallinity, and an antioxidant package that does not suppress the required microbial inactivation. The operational limit is that any post-irradiation thermal treatment must not exceed the melting temperature of the physical crystallites, typically 60–65 °C, and must be validated to show no increase in soluble polymer fraction or reduction in sterility assurance.

Primary packaging material selection for radiation-sterilized wound hydrogels is not a passive afterthought because the package headspace oxygen concentration and water vapour transmission rate control the post-irradiation radical chemistry. A sealed foil laminate with oxygen transmission rate below 0.01 cm³ m⁻² day⁻¹ at 23 °C and 0% RH may prevent exogenous oxygen ingress, but oxygen dissolved in the hydrogel before sealing remains available for peroxyl radical formation. Nitrogen flushing to reduce headspace oxygen below 2% is often combined with a vacuum-drawn lidding film; however, the vacuum level must not exceed the gel’s elastic limit, or the dressing will be crushed and the network structure will be irreversibly densified. For freeze-thaw PVA gels, compression set under vacuum of 50 mbar for 10 s can reduce the dressing thickness by 20–30% and increase the effective modulus in a manner that is not fully recovered after unpacking. The packaging process must be validated to show that the oxygen scavenger, if used, does not react with the hydrogel or alter its pH. A radiation-sterilized wound hydrogel packaged in a tray with a high water vapour barrier and stored at 25 °C for 24 months may still undergo slow chain scission due to trapped radicals; this is the reason that post-irradiation storage modulus and gel fraction are evaluated at time zero and at stability intervals. The shelf-life specification should state the maximum allowed change in G′ at 1.0 rad s⁻¹, yield stress, and equilibrium swelling ratio, not just sterility and package integrity.

Sterility assurance for a radiation-sterilized hydrogel is based on dose substantiation rather than final product sterility testing; ISO 11137-2:2013 method VDmax25 allows a 25 kGy sterilization dose for products with a bioburden of 1–100 CFU per device, provided the bioburden recovery method is validated per ISO 11737-1:2018. The biological reduction and the physical gel changes are not completely decoupled because the same water radiolysis species that inactivate DNA and membranes also attack the polymer matrix. A production line that observes bioburden excursions above the substantiated level cannot simply increase the sterilization dose without re-qualifying the hydrogel network, because the higher dose may convert an acceptable physical gel into a non-compliant sol. This is the central process conflict in radiation-sterilized wound hydrogels: the dose that satisfies statutory sterility assurance may be higher than the dose the physical network can tolerate, and the resolution requires formulation-level modification rather than process-level adjustment alone. The dose audit requirements of ISO 11137-2:2013 and AAMI TIR29:2020 are therefore applied in parallel with rheological and swelling measurements. A manufacturer that uses a 15 kGy substantive dose based on low bioburden must document that the lower dose remains within the validated range of the network and that the sterility assurance level of 10⁻⁶ is maintained for the entire product line. The use of high-energy radiation at a low dose rate does not automatically preserve physical gel properties; in fact, gamma processing at 1 kGy h⁻¹ permits more oxygen diffusion into the package during irradiation than e-beam processing at 10⁶ kGy h⁻¹, so the net oxidative yield can be higher even when the total dose is identical.

The compliance matrix below lists the test methods, standard designations, and acceptance criteria typically used to demonstrate that radiation-sterilized physical wound hydrogels retain their network integrity and regulatory compliance. The criteria are expressed as ranges because the acceptable values depend on the specific polymer system, dressing type, and clinical use; each manufacturer must establish product-specific specifications under ISO 13485:2016 design and development controls.